Project Description


Chief Executive Officer

Global Center for Medical Innovation (GCMI) & T3 Labs


Tiffany has spent more than 15 years bringing innovative medical technology from benchtop to bedside. She leads the Global Center for Medical Innovation, a non-profit organization that represents the Southeast’s first medical device innovation center.  GCMI has supported over 100 innovative medical technologies making their way through design, prototype, preclinical testing, and clinical trials to commercialization.  The organization acquired T3 Labs from Emory Healthcare in 2016 and is catalyzing a highly capital efficient method approach to move innovation to products that impact patient outcomes and healthcare efficiently.


Tiffany joined GCMI from Scientific Intake, where she was VP of Business Development & Strategy.  In 2002, she launched ACell as VP of Corporate Strategy & Finance, leading a broad range of initiatives, including regulatory, reimbursement, and the scientific advisory board. A former consultant & investment banker, she brings considerable experience in strategic planning, business development, operations, and financial analysis.


Tiffany serves as Past-President of the Board of the Southeast Medical Device Association (SEMDA), Founding Member of Medtech Women @ SEMDA, Chair of the T3 Labs Advisory Board, and the Georgia Bio Board of Directors. She is a Member of the National Advisory Council on Innovation and Entrepreneurship (NACIE) at the U.S. Department of Commerce. She led the Sponsorship Committee of the 2013 SEMDA Conference and has served as the Co-Chair of the Medical Device Subcommittee of the Metro Atlanta Chamber Bioscience Leadership Council. In 2015 Tiffany received the prestigious Georgia Bio Community Award and in 2017 was presented with the Industry Growth Award, the highest honor bestowed each year by Georgia Bio.  She was recently recognized by Inc. Magazine as one of “17 Inspiring Women to Watch in 2017” and one of Becker Hospital Review’s “110 Women in Medtech to Know in 2017”.